IMHO the reason that we get no interest is because we don't own the molecule and don't have the IP or facility or now the money to manufacture it. If big pharma are going to fork out money for this they will give it to benepharma with us as the little sales office.
- Forums
- ASX - By Stock
- PAR
- PAR. SP
PAR. SP, page-696
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.0¢ |
Change
0.030(6.82%) |
Mkt cap ! $182.9M |
Open | High | Low | Value | Volume |
45.0¢ | 47.5¢ | 44.5¢ | $750.5K | 1.622M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 18144 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 16379 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 18144 | 0.465 |
1 | 200000 | 0.460 |
2 | 1209 | 0.455 |
2 | 212800 | 0.450 |
3 | 28179 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 16379 | 1 |
0.475 | 5000 | 1 |
0.480 | 61318 | 4 |
0.485 | 76500 | 2 |
0.490 | 89224 | 5 |
Last trade - 16.10pm 24/01/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
AVM
ADVANCE METALS LIMITED
Adam McKinnon, MD
Adam McKinnon
MD
SPONSORED BY The Market Online